(E)-3-[5-[(Z)-(3-oxo-4H-1,4-benzoxazin-2-ylidene)methyl]furan-3-yl]-N-(pyridin-3-ylmethyl)prop-2-enamide | 1135619-70-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并恶嗪类
• 英文名称: (E)-3-[5-[(Z)-(3-oxo-4H-1,4-benzoxazin-2-ylidene)methyl]furan-3-yl]-N-(pyridin-3-ylmethyl)prop-2-enamide
• CAS: 1135619-70-3
• 化学式: C₂₂H₁₇N₃O₄
• 分子量: 387.395
• InChiKey: JWOFTHVYYGZPDN-SKRUYSPESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  29
• 可旋转键数：
  5
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.05
• 拓扑面积：
  93.5
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  3-氨甲基吡啶 、 (E)-N-(4-morpholinophenyl)-3-(3-((Z)-(3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-2-ylidene)methyl)phenyl)acrylamide 以 N,N-二甲基甲酰胺 为溶剂， 生成 (E)-3-[5-[(Z)-(3-oxo-4H-1,4-benzoxazin-2-ylidene)methyl]furan-3-yl]-N-(pyridin-3-ylmethyl)prop-2-enamide
  参考文献：
  名称：

  Synthesis of novel 1,4-benzoxazin-3-one derivatives as inhibitors against tyrosine kinases

  摘要：

  We designed and synthesized a novel 1,4-benzoxazin-3-one derivative 4 which would have inhibitory activities against tyrosine kinases. They could be synthesized easily from various carboxylic acids 10 and commercially available amines using TFP resin without purification. In this article, we will report the design and synthesis of a novel 1,4-benzoxazin-3-one chemical library 4 and the inhibitory activities against KDR and ABL which are closely related to chronic diseases such as cancer. (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2008.11.060

文献信息

• Synthesis of novel 1,4-benzoxazin-3-one derivatives as inhibitors against tyrosine kinases
  作者：Takahiro Honda、Takahiro Terao、Hiroyuki Aono、Masakazu Ban

  DOI：10.1016/j.bmc.2008.11.060

  日期：2009.1

  We designed and synthesized a novel 1,4-benzoxazin-3-one derivative 4 which would have inhibitory activities against tyrosine kinases. They could be synthesized easily from various carboxylic acids 10 and commercially available amines using TFP resin without purification. In this article, we will report the design and synthesis of a novel 1,4-benzoxazin-3-one chemical library 4 and the inhibitory activities against KDR and ABL which are closely related to chronic diseases such as cancer. (C) 2008 Elsevier Ltd. All rights reserved.